# Neuroimaging Markers of Midlife Depression and Cognitive Behavioural Therapy (CBT)

> **NCT07091643** · NA · NOT_YET_RECRUITING · sponsor: **Baycrest** · enrollment: 30 (estimated)

## Conditions studied

- Major Depressive Disorder (MDD)

## Interventions

- **BEHAVIORAL:** Cognitive Behavioural Therapy

## Key facts

- **NCT ID:** NCT07091643
- **Lead sponsor:** Baycrest
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07091643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07091643, "Neuroimaging Markers of Midlife Depression and Cognitive Behavioural Therapy (CBT)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07091643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*